Disulfiram in Recurrent Glioblastoma

NCT02678975 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Glioma
Glioblastoma

Interventions

DRUG: Disulfiram
DIETARY_SUPPLEMENT: Copper
DRUG: Alkylating Agents

Sponsor

Sahlgrenska University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]